Stay updated with breaking news from Oxitope Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With a shared focus on developing disease modulating treatments, Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx) have merged to form a new clinical stage company, Calluna Pharma Inc. Click to read more...
Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Vasculitis Pipeline constitutes 30+ key companies continuously working towards developing 30+ Vasculitis treatment therapies, analyzes DelveInsight...